Legend Biotech USA Growth, Revenue, Number of Employees and Funding
Estimated Revenue & Financials
- Legend Biotech USA's estimated revenue is currently $17.7M per year.
- Legend Biotech USA's estimated revenue per employee is $144836
- Legend Biotech USA has 122 Employees.
- Legend Biotech USA grew their employee count by 149% last year.
- Legend Biotech USA currently has 23 job openings.
|Jerry Zhou||Associate Director of Finance|
|Steve Gavel||Vice President, Commercial Development|
|Bryan Utter||Assoc Director of Product Dev and Commercialization|
|Mike Hirschmann||Executive Director Commecial Development|
|Syed Rizvi||VP & Head Clinical Development, Medical Affairs, Data Sciences, & Product Safety|
|Robert Jankowski||Sr. Director, Hem/Onc MSLs|
|Alan Kick||VicePresident, Global Quality|
|Jianxin Ye||Senior Director, CMC Regulatory|
|Linh Nguyen Minore||Sr. Director of Quality Operations|
|Nina Lepski||Senior Director, Compliance, Training and Audits|
What Is Legend Biotech USA?
Legend Biotech Corporation is an emerging company focusing on the development of the best-in-class immunotherapy technology for cancer cure. Teamed up with outstanding immunologists and molecular biologists, Legend has generated a strong pipeline of Chimeric Antigen Receptor(CAR) product candidates to treat a wide variety of liquid and solid tumors. Our ambition to succeed in the CARs field has been substantially fulfilled by the latest clinical trial results that we have achieved a great clinical success in treating multiple myeloma, a previously incurable blood cancer. By applying one of our proprietary CAR-T technology, we have reached a promising result in the clinical research for the enrolled patient group bearing refractory and relapsed multiple myeloma. Legend Biotech Corporation is founded on the vision that the previous incurable previousincurable cancer will be safely and effectively treated with fine-tuning products generated on our innovative technology platform. We take our mission very seriously and intend to bring more hopes to desperate patients all over the world.keywords:N/A
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|L Oreal USA||N/A||0||N/A|
|Legend Biotech ...||$17.7M||122||149%|
Legend Biotech USA News
... Sorrento Therapeutics (US), Legend Biotech (US), Mustang Bio (US), ... The US is expected to hold the largest share of the global CAR T cell ...
Micro-cap biotech Aridis Pharmaceuticals $ARDS got hammered this ... drug status by US and EU regulators for its experimental drug, elafibranor, ... pit Immunotech against Legend Biotech, a J&J-partnered player owned by ...
In 2017, Janssen entered into a global collaboration and licence agreement with Legend Biotech USA and Legend Biotech Ireland to develop, ...